Dergiler / Dicle Tıp Dergisi / 2021 / Cilt: 48 - Sayı: 3

Metabolic Effectiveness of Laparoscopic Sleeve Gastrectomy in Morbid Obesity Treatment: Early and Mid-Term Results of a Single Center

Morbid Obezite Tedavisinde Laparoskopik Sleeve Gastrektominin Metabolik Etkinliği: Tek Merkezin Erken ve Orta Dönem Sonuçları

Sayfa
478–487
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

However, there is a need for more comprehensive randomized studies evaluating the long-term results of LSG.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The aim of this study is to reveal the efficacy of laparoscopic sleeve gastrectomy (LSG) in the preventable metabolic consequences of morbid obesity.
📊
Temel Bulgular & Veri:We evaluated the weight loss according to body mass index (BMI), changes in comorbid diseasesaccompanying obesity in patients who underwent surgery in our clinic in the early and mid-period postoperatively, whether there was vitamin deficiency in the mid-term, and the complications associated with the surgery.Methods: In this study, a total of 50 patients aged 18-60 who underwent LSG intervention due to morbid obesity between January 1, 2010 and December 2019 by Dicle University School of Medicine, General Surgery Clinic, were retrospectively evaluated.
💡
Sonuç & Katkı:However, there is a need for more comprehensive randomized studies evaluating the long-term results of LSG.
🔬Tür:Araştırma Makalesi
📍Kapsam:2010 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: The aim of this study is to reveal the efficacy of laparoscopic sleeve gastrectomy (LSG) in the preventable metabolic consequences of morbid obesity. We evaluated the weight loss according to body mass index (BMI), changes in comorbid diseasesaccompanying obesity in patients who underwent surgery in our clinic in the early and mid-period postoperatively, whether there was vitamin deficiency in the mid-term, and the complications associated with the surgery.Methods: In this study, a total of 50 patients aged 18-60 who underwent LSG intervention due to morbid obesity between January 1, 2010 and December 2019 by Dicle University School of Medicine, General Surgery Clinic, were retrospectively evaluated. Sociodemographic data of the patients, preoperative BMI, postoperative 3th month, 6th month and 1st year BMI values, preoperative and postoperative 12th month HgA1c levels were measured. Mortality and complication rates were evaluated.Results: The mean BMI of 50 patients at pre-LSG, postoperative 3rd month, 6th month and 1st year controls were respectively; 45.83±6.37, 37.63±5.88, 31.91±5.10 and 26.82±3.08kg/m2. Compared to before the intervention, the decrease in BMI was significant at the 3rd month, 6th month and 1st year controls (p <0.05). When paired comparisons were made, the BMI at the 1st year control was lower than the 6th and 3rd month (p<0.05). It was found that the preoperative HbA1c level of 6.55±1.37 decreased to 5.32±0.57 in the postoperative 12th month (p<0.05). Complication rate was determined as 2%. No mortality was observed during the follow-up.Conclusion: As a result of this study, it has been shown that LSG provides sufficient weight loss. In addition, LSG was found to be effective in achieving glycemic control and remission in Type 2 diabetes. In this study where mortality was not observed, LSG, which is a reliable method with acceptable operation time and postoperative complication rates, seems to be an effective solution in the surgical treatment of obesity. However, there is a need for more comprehensive randomized studies evaluating the long-term results of LSG.

Abstract

Amaç: Bu çalışmanın amacı morbid obezitenin önlenebilir metabolik sonuçlarında yapılan laparoskopik sleeve gastrektominin (LSG) etkinliğini ortaya koymaktır. Kliniğimizde ameliyat olan hastaların ameliyat sonrası erken ve orta dönemde vücut kitle indeksine (VKİ) göre kilo kayıplarını, obeziteye eşlik eden komorbid hastalıklardaki değişimlerini, orta dönemde vitamin eksikliğinin olup olmadığını ve ameliyatla ilişkili komplikasyonları değerlendirdik. Yöntemler: Bu çalışmada Dicle Üniversitesi Tıp Fakültesi Genel Cerrahi Kliniği tarafından 1 Ocak 2010- Aralık 2019 tarihleri arasında, morbid obezite nedeniyle LSG girişimi uygulanan 18-60 yaş arası toplam 50 hasta retrospektif olarak değerlendirildi. Hastaların sosyodemografik verileri ile preoperatif VKİ, postoperatif 3.ay, 6.ay ve 1.yıl VKI değerleri, preoperatif ve postoperatif 12.ay HgA1c düzeylerine bakıldı. Mortalite ve komplikasyon oranları değerlendirildi. Bulgular: Elli hastanın LSG öncesi, operasyon sonrası 3.ay, 6.ay ve 1.yıl kontrollerindeki ortalama VKİ sırasıyla; 45.83±6.37, 37.63±5.88, 31.91±5.10 ve 26.82±3.08kg/m2 olarak bulundu. Girişim öncesine göre, 3.ay, 6.ay ve 1.yıl kontrollerinde VKİ’ndeki düşüş anlamlı idi (p<0.05). İkili karşılaştırmalar yapıldığında, 1. yıl kontrolündeki VKİ 6.aya ve 3.aya göre daha azdı (p<0.05). Preoperatif HbA1c 6.55± 1.37 düzeyinin postoperatif 12.ayda 5.32±0.57’ye gerilediği tespit edildi (p<0.05). Komplikasyon oranı %2 olarak tespit edildi. Takip süresince mortalite izlenmedi. Sonuç: Bu çalışmanın sonucunda LSG’nin yeterli düzeyde kilo kaybı sağladığı gösterildi. Ayrıca LSG’nin glisemik kontrol ve Tip 2 diyabette remisyon sağlamada da etkili olduğu saptandı. Mortalitenin gözlenmediği bu çalışmada, kabul edilebilir operasyon süresi ve postoperatif komplikasyon oranları ile güvenilir bir yöntem olan LSG, obezitenin cerrahi tedavisinde etkili bir çözüm gibi görünmektedir. Bununla birlikte LSG’nin uzun dönem sonuçlarının değerlendirildiği daha kapsamlı randomize çalışmalara ihtiyaç vardır.

🔖

Bu Makaleye Atıf Yap

KIRŞAN, M. A., KAFADAR, M., OĞUZ, A. (2021). Metabolic Effectiveness of Laparoscopic Sleeve Gastrectomy in Morbid Obesity Treatment: Early and Mid-Term Results of a Single Center. Dicle Tıp Dergisi, Cilt: 48 - Sayı: 3, 478–487. https://ajindex.com/articles/348755

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Cummings DE, Rubino F. Metabolic surgery for the treatment of type 2 diabetes in obese individuals. Diabetologia. 2018; 61: 257-64
  2. Schauer PR, Bhatt DL, Kirwan JP, et al.; STAMPEDE Investigators. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017; 376: 641-51
  3. Sethi P, Thillai M, Nain PS, Ahuja A, Aulakh N, Khurana P. Role of Hunger Hormone "Ghrelin" in Long-Term Weight Loss Following Laparoscopic Sleeve Gastrectomy. Niger J Surg. 2018; 24: 121-4
  4. Benaiges D, Más-Lorenzo A, Goday A, et al. Laparoscopic sleeve gastrectomy: More than a restrictive bariatric surgery procedure? World J Gastroenterol. 2015; 21: 11804-14
  5. Sharma G, Nain PS, Sethi P, Ahuja A, Sharma S. Plasma ghrelin levels after laparoscopic sleeve gastrectomy in obese individuals. Indian J Med Res. 2019; 149: 544-7
  6. Su DW, Wei WW, Yao RR, Yang CJ, Tian H. Research on sleeve gastrectomy for the treatment of rats with type 2 diabetes mellitus and the regulation of ghrelin and intestinal lesions. Eur Rev Med Pharmacol Sci. 2020; 24: 10653-62
  7. Mehdar KM, Alsareii SA, Alshafie SEM, Al-Rafiah AR, Alamri AM. Ghrelin gastric tissue expression in patients with morbid obesity and type 2 diabetes submitted to laparoscopic sleeve gastrectomy: immunohistochemical and biochemical study. Folia Histochem Cytobiol. 2020; 58: 235-46
  8. Shantavasinkul PC, Torquati A, Corsino L. Postgastric bypass hypoglycaemia: a review. Clin Endocrinol (Oxf). 2016; 85: 3-9
  9. Albeladi B, Bourbao-Tournois C, Huten N. Shortand midterm results between laparoscopic Roux-enY gastric bypass and laparoscopic sleeve gastrectomy for the treatment of morbid obesity. J Obes. 2013; 2013: 934653
  10. Baltasar A, Serra C, Pérez N, Bou R, Bengochea M, Ferri L. Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes Surg. 2005; 15: 1124-8
  11. Palermo M, Serra E. Laparoscopic Sleeve Gastrectomy: How Do I Do It. J Laparoendosc Adv Surg Tech A. 2020; 30: 2-5
  12. Mihmanli M, Isil RG, Bozkurt E, et al. Postoperative effects of laparoscopic sleeve gastrectomy in morbid obese patients with type 2 diabetes. Springerplus. 2016; 5: 497
  13. Baştürk S. Sleeve gastrektomi’nin orta ve uzun dönem sonuçları, obeziteye eşlik eden komorbiditelere etkileri, Uzmanlık Tezi, 2015, Denizli
  14. Chang X, Cai H, Yin K. The Regulations and Mechanisms of Laparoscopic Sleeve Gastrectomy (LSG) for Obesity and Type 2 Diabetes: A Systematic Review. Surg Laparosc Endosc Percutan T